Parkinson disease: open trials in Netherlands

• NCT07174310

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Brain Research Center Amsterdam B.V., Amsterdam · Brain Research Center Den Bosch B.V., 's-Hertogenbosch · Brain Research Center Zwolle B.V., Zwolle

  Registry updated 2026-11-05

• NCT06399731

  Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

  Trial Treatment · Amsterdam UMC

  Amsterdam UMC, Amsterdam

  Registry updated 2026-10-29

• NCT06561919

  STIMPulseControl Ancillary Speech Study

  Trial Treatment · Steffen Paschen

  Amsterdam University Medical Center, Amsterdam

  Registry updated 2026-10-22

• NCT06976268

  A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  Trial Treatment · Phase 2/3 · Biohaven Therapeutics Ltd.

  Brain Research Center Amsterdam B.V., Amsterdam · UMCG, Groningen · Leids Universitair Medisch Centrum (LUMC), Leiden · Radboud universitair medisch centrum Stichting, Nijmegen · Brain Research Center Den Bosch B.V., 's-Hertogenbosch

  Registry updated 2026-10-22

• 2024-511110-21-00

  A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.

  Trial Treatment · Phase 1 · F. Hoffmann-La Roche AG

  Brain Research Center Amsterdam B.V., Amsterdam · Pharmaceutical Research Associates Group B.V., Groningen · Radboud universitair medisch centrum Stichting, Nijmegen · Brain Research Center Den Bosch B.V., 's-Hertogenbosch · Brain Research Center Zwolle B.V., Zwolle

  Registry updated 2026-10-20

• NCT06498349

  Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl

  Trial Treatment · University of Kiel

  Amsterdam University Medical Center, Amsterdam

  Registry updated 2026-10-20

• NCT07781644

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  Trial Treatment · Phase 1/2 · Hoffmann-La Roche

  Brain Research Center Amsterdam B.V., Amsterdam · Brain Research Center Den Bosch B.V., 's-Hertogenbosch · Brain Research Center Zwolle B.V., Zwolle

  Registry updated 2026-10-20

• NCT06565195

  A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

  Trial Treatment · Phase 1 · Prevail Therapeutics

  CTC Netherlands BV, Groningen · Radboud universitair medisch centrum Stichting, Nijmegen

  Registry updated 2026-10-16

• NCT06993142

  Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

  Trial Treatment · Radboud University Medical Center

  Radboud University Medical Center, Nijmegen

  Registry updated 2026-10-15

• NCT07216066

  First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

  Trial Treatment · Phase 1 · Regeneron Pharmaceuticals

  Centre for Human Drug Research, Leiden

  Registry updated 2026-09-21

• NCT07105280

  Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease

  Trial Treatment · HagaZiekenhuis

  Amsterdam UMC, Amsterdam · Maastricht UMC, Maastricht

  Registry updated 2026-09-10

• 2026-525848-15-00

  A Phase 2 study of VQ-101 in participants with Parkinson’s disease and GBA1 mutation

  Trial Treatment · Phase 2 · Vanqua Bio Inc.

  Radboud universitair medisch centrum Stichting, Nijmegen

  Registry updated 2026-09-07

• NCT06193252

  Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands

  Trial Treatment · Radboud University Medical Center

  Radboud University Medical Center, Nijmegen

  Registry updated 2026-08-27

• NCT07175922

  Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

  Research · Vertero Therapeutics

  Center for Human Drug Research, Leiden

  Registry updated 2026-08-19

• NCT07322887

  A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease

  Trial Treatment · Phase 2 · GEN İlaç ve Sağlık Ürünleri A.Ş.

  CTC Netherlands B.V., Groningen

  Registry updated 2026-08-17

• NCT04477785

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  Research · Michael J. Fox Foundation for Parkinson's Research

  Radboud University, Nijmegen

  Registry updated 2026-07-27

• 2025-523872-22-00

  Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS

  Trial Treatment · Phase 1 · Nrg Therapeutics Limited

  Centre for Human Drug Research, Leiden

  Registry updated 2026-07-09

• 2024-516756-18-00

  Pharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-modal approach.

  Trial Treatment · Phase 3 · Stichting Radboud universitair medisch centrum

  Radboud universitair medisch centrum Stichting, Nijmegen · Radboud Universiteit Nijmegen, Nijmegen

  Registry updated 2026-05-13

• NCT06782724

  Psilocybin Therapy for Psychological Distress in Palliative Patients

  Trial Treatment · Phase 2 · University Medical Center Groningen

  Universitair Medisch Centrum Groningen, Groningen

  Registry updated 2026-05-08

• NCT07310264

  Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

  Trial Treatment · Phase 1 · Vertero Therapeutics

  Centre for Human Drug Research, Leiden

  Registry updated 2026-03-20

• NCT06416345

  Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

  Trial Treatment · Amsterdam UMC, location VUmc

  Amsterdam UMC location VUmc, Amsterdam · Radboudumc, Nijmegen

  Registry updated 2026-03-16

• NCT07316296

  Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach

  Trial Treatment · Phase 3 · Radboud University Medical Center

  Radboudumc, Nijmegen

  Registry updated 2026-02-27

• 2024-510629-24-00

  Management of Parkinson's disease if levodopa is broken down prematurely

  Trial Treatment · Phase 2 · Stichting Radboud University Medical Center

  Radboud universitair medisch centrum Stichting, Nijmegen

  Registry updated 2026-02-04

• NCT06909045

  Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

  Trial Treatment · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  Amsterdam UMC, Amsterdam · Maastricht UMC, Maastricht · HagaZiekenhuis, The Hague

  Registry updated 2026-01-29

• 2024-518865-85-00

  Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease

  Trial Treatment · Phase 2 · Universitair Medisch Centrum Groningen

  Universitair Medisch Centrum Groningen, Groningen

  Registry updated 2026-01-19

All Parkinson disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error